Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF

Neovascular retinopathies are leading causes of irreversible blindness. Although vascular endothelial growth factor (VEGF) inhibitors have been established as the mainstay of current treatment, clinical management of these diseases is still limited. As retinal impairment involves abnormal neovascula...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridano, Magali E., Subirada, Paula V., Paz, María C., Lorenc, Valeria E., Stupirski, Juan C., Gramajo, Ana L., Luna, José D., Croci, Diego O., Rabinovich, Gabriel A., Sánchez, María C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464805/
https://www.ncbi.nlm.nih.gov/pubmed/28455954
http://dx.doi.org/10.18632/oncotarget.17129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464805/
https://www.ncbi.nlm.nih.gov/pubmed/28455954
http://dx.doi.org/10.18632/oncotarget.17129

Ejemplares similares